These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Serotoninergic agonists increase plasma levels of beta-endorphin and beta-lipotropin in humans. Petraglia F; Facchinetti F; Martignoni E; Nappi G; Volpe A; Genazzani AR J Clin Endocrinol Metab; 1984 Dec; 59(6):1138-42. PubMed ID: 6092410 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat. Nagahama S; Chen YF; Oparil S J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675 [TBL] [Abstract][Full Text] [Related]
6. Hyperendorphinemia in obese children and adolescents. Genazzani AR; Facchinetti F; Petraglia F; Pintor C; Corda R J Clin Endocrinol Metab; 1986 Jan; 62(1):36-40. PubMed ID: 2933422 [TBL] [Abstract][Full Text] [Related]
7. Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe. Lamberts SW; Uitterlinden P; Bons EG; Zuiderwijk JM; Verleun T; Oosterom R; Hackeng WH Endocrinology; 1984 Jun; 114(6):2349-53. PubMed ID: 6327244 [TBL] [Abstract][Full Text] [Related]
9. Discrimination between beta-endorphin and beta-lipotrophin in human plasma using two-site immunoradiometric assays. Gibson S; Crosby SR; White A Clin Endocrinol (Oxf); 1993 Oct; 39(4):445-53. PubMed ID: 8287571 [TBL] [Abstract][Full Text] [Related]
10. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays. Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708 [TBL] [Abstract][Full Text] [Related]
11. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels. Autelitano DJ; Clements JA; Nikolaidis I; Canny BJ; Funder JW Endocrinology; 1987 Nov; 121(5):1689-96. PubMed ID: 2959468 [TBL] [Abstract][Full Text] [Related]
12. A role for dopamine in growth hormone regulation in the dog. Casanueva F; Betti R; Cocchi D; Zanardi P; Motta T; Müller EE Endocrinology; 1981 Apr; 108(4):1469-75. PubMed ID: 7472276 [TBL] [Abstract][Full Text] [Related]
14. Effect of electroimmobilisation on ovine plasma concentrations of beta-endorphin/beta-lipotrophin, cortisol and prolactin. Jephcott EH; McMillen IC; Rushen J; Hargreaves A; Thorburn GD Res Vet Sci; 1986 Nov; 41(3):371-7. PubMed ID: 2949354 [TBL] [Abstract][Full Text] [Related]
15. Peripheral opioid secretory pattern in anorexia nervosa. Brambilla F; Ferrari E; Petraglia F; Facchinetti F; Catalano M; Genazzani AR Psychiatry Res; 1991 Nov; 39(2):115-27. PubMed ID: 1665917 [TBL] [Abstract][Full Text] [Related]
16. Bromocriptine is unable to suppress TRH-stimulated beta-endorphin/beta-lipotropin and cortisol secretion in normal pregnant women after delivery. Lamberts SW; Angement R; van der Heijden A; Wladimiroff JW; Hackeng WH; de Jong FH Horm Res; 1987; 27(4):195-9. PubMed ID: 2963790 [TBL] [Abstract][Full Text] [Related]
17. Dopaminergic regulation of alpha-melanocyte-stimulating hormone and N-acetyl-beta-endorphin secretion in the fetal lamb. Newman CB; Wardlaw SL; Stark RI; Daniel SS; Frantz AG Endocrinology; 1987 Mar; 120(3):962-6. PubMed ID: 3803322 [TBL] [Abstract][Full Text] [Related]